spacer

LigPlot+ - request for academic version

Commercial users (pharmaceutical and biotech): please contact Mark Swindells at mark.swindells@ebisu.co.uk. There is an annual charge for commercial usage.

To obtain the free academic version of LigPlot+, please fill in the form below, providing your name, institution address and institutional e-mail address (ie not gmail, hotmail, yahoo, etc).

On approval of your application, you will receive a password by e-mail which will allow you to download a licenced version of the software. Approval may take a day or two - longer during holiday periods. The licence is renewable annually using the same e-mail address and password.

Note. If you have previously applied for a licence and been given a password, please go directly to the Download page to get the current version of LigPlot+ and extend your licence for another year. (If you have forgotten your password, the Download page will offer to retrieve it for you).

Your details

  All fields are required
Your first name
Your last name
Department
Name of institute
Address
Country
  E-mail address must be an institutional one (ie not gmail, hotmail, yahoo, etc)
E-mail address
Re-enter e-mail address
  I HAVE READ AND ACCEPT THE LICENCE TERMS AND CONDITIONS FOR LigPlot+
 

BY CHECKING THE BOX MARKED "I HAVE READ AND ACCEPT THE LICENCE TERMS AND CONDITIONS FOR LigPlot+" AND CLICKING ON THE BUTTON MARKED "ACCEPT" THAT FOLLOWS IT, YOU INDICATE ACCEPTANCE OF THIS LICENCE AGREEMENT AND THE LIMITED WARRANTY AND LIMITATION OF LIABILITY SET OUT IN IT. SUCH ACCEPTANCE IS EITHER ON YOUR OWN BEHALF OR ON BEHALF OF ANY CORPORATE ENTITY WHICH EMPLOYS YOU OR WHICH YOU REPRESENT ('CORPORATE LICENSEE'). IN THIS LICENCE AGREEMENT, 'YOU' INCLUDES BOTH THE READER AND ANY CORPORATE LICENSEE.

IF YOU DO NOT ACCEPT THESE TERMS AND CONDITIONS, YOU SHOULD NOT CHECK THE BUTTON.

THESE TERMS AND CONDITIONS APPLY TO THE SOFTWARE AS AMENDED OR SUPPLEMENTED BY ANY PATCH, UPDATE OR NEW RELEASE ISSUED TO YOU.

For further information you can contact us via the Contact page